Research Article
Network Pharmacology-Based Strategy and Molecular Docking to Explore the Potential Mechanism of Jintiange Capsule for Treating Osteoporosis
Table 1
Targets of tiger bone’s main ingredients.
| Main ingredients | Uniprot ID | Protein | Gene symbol |
| Calcium phosphate | P41180 | Extracellular calcium-sensing receptor | CASR | P27797 | Calreticulin | CALR | Q99828 | Calcium and integrin-binding protein 1 | CIB1 | O75340 | Programmed cell death protein 6 | PDCD6 | P30626 | Sorcin | SRI | Q99653 | Calcineurin B homologous protein 1 | CHP1 | P09486 | SPARC | SPARC | P27824 | Calnexin | CANX | P35556 | Fibrillin-2 | FBN2 | P04271 | Protein S100-B | S100B | O14958 | Calsequestrin-2 | CASQ2 | Q15493 | Regucalcin | RGN | Q9UBV8 | Peflin | PEF1 | P06703 | Protein S100-A6 | S100A6 | P13693 | Translationally controlled tumor protein | TPT1 | O75838 | Calcium and integrin-binding family member 2 | CIB2 | Q99584 | Protein S100-A13 | S100A13 | P31415 | Calsequestrin-1 | CASQ1 | Q02818 | Nucleobindin-1 | NUCB1 | P80303 | Nucleobindin-2 | NUCB2 | P0DP23 | Calmodulin | CALM1 | Q75N90 | Fibrillin-3 | FBN3 | P28676 | Grancalcin | GCA | Q9ULU8 | Calcium-dependent secretion activator 1 | CADPS | P0DP24 | Calmodulin-2 | CALM2 | P0DP25 | Calmodulin-3 | CALM3 | Q96FQ6 | Protein S100-A16 | S100A16 | P22676 | Calretinin | CALB2 | Q13938 | Calcyphosin | CAPS | Q86UW7 | Calcium-dependent secretion activator 2 | CADPS2 | Q96L12 | Calreticulin-3 | CALR3 | Q9ULB1 | Neurexin-1 | NRXN1 | P62166 | Neuronal calcium sensor 1 | NCS1 |
| Magnesium phosphate | No ID | No protein | No target | Osseocolla | No ID | No protein | No target | Fat | No ID | No protein | No target |
|
|